Stay updated on Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page.

Latest updates to the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedThe study record now displays “TypeError: Failed to fetch” instead of a 403 Forbidden error, and the NIH transition announcement is no longer shown.SummaryDifference1%

- Check21 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide notice announces NIH’s transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision marker changed from v3.7.1 to v3.7.2; the page still displays a 403 error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check62 days agoChange DetectedA 403 Forbidden page now appears when attempting to view the study record, blocking access to the study details. The previous content is replaced by the 403 message along with the site header and footer.SummaryDifference18%

Stay in the know with updates to Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page.